SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-059725
Filing Date
2009-11-16
Accepted
2009-11-16 15:42:05
Documents
1
Period of Report
2009-11-16

Document Format Files

Seq Description Document Type Size
1 v166684_ex.html 4  
1 v166684_ex.xml 4 3948
  Complete submission text file 0001144204-09-059725.txt   5700
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 HARBOUR SQUARE STE 202 TORONTO A6 M5H2G2
Business Address
GLUSKIN ANNA E (Reporting) CIK: 0001125857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 091186502